Skip to main navigation Offerings Company Clinical Excellence Support Investors Careers United States Login Investor Relations Investor Overview Our Strategy Financials Press Releases Events and Presentations Governance ESG Resources Investor Relations NYSE: BDX $244.46 $-2.12 (-0.86%) Data as of Nov 24, 2021 4:10 PM ET Data provided by Refinitiv. Minimum 15 minutes delayed. BD is advancing the world of health™ For nearly 125 years, BD has been advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. We are a clear category leader, with key platforms in many large, foundational areas of healthcare and the global reach, and scale to address healthcare’s most pressing challenges. We're investing in our human capital, advancing our culture of inclusion, diversity, and equality while fostering a growth mindset and empowering our associates globally to ensure long-term organizational success. Learn more about BD’s 2025 strategy 70,000+ BD Associates 190+ Countries Served 40B+ Devices Made Annually $1B+ Annual R&D Spending 27,000+ Active Patents Recent Press Releases Nov 24, 2021 BD Names Francesca DeMartino as Senior Vice President of Investor Relations Nov 12, 2021 BD to Highlight Progress Against BD 2025 Strategy and Plans for Long-Term Growth Nov 04, 2021 BD Announces Fourth Fiscal Quarter And Full Year 2021 Results; Issues Fiscal Year 2022 Guidance View all news Events and Presentations Nov 12, 2021 at 8:00 AM ET BD 2021 Virtual Investor Day Nov 4, 2021 at 8:00 AM ET Q4 FY21 BD Earnings Conference Call View all events Q4 FY21 Earnings Press Release Presentation Webcast View all financial reports Featured Reports 2020 Annual Report Download PDF 2020 Sustainability Report Download PDF 2019 Climate Change Management Report Download PDF By reading this content you are acknowledging our forward looking statement. SEC Filings/Section 16 Alerts Press Releases Alerts Annual Report Alerts Annual Reports/Proxy Alerts Questions for the Investor Relations department can be addressed to: 1-800-284-6845 investor.relations@bd.com BD Attn: Investor Relations 1 Becton Drive Franklin Lake, NJ 07417 OFFERINGS Capabilities Brands Integrated solutions Catalogs COMPANY Contact us BD code of conduct Careers Inclusion and Diversity Sustainability Suppliers News Investors Video gallery External Funding Program CLINICAL EXCELLENCE Case studies Events Webcasts Training SUPPORT Technical support Product security and privacy Live chat Order status Customer portals Alerts and notices Electronic Instructions for Use COVID-19 © 2021 BD. All rights reserved. Unless otherwise noted, BD, the BD Logo and all other trademarks are the property of Becton, Dickinson and Company or its affiliates. Privacy | Terms of Use | Cookies Settings By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Reject All Accept All Cookies